Search - tctmd.com

Displaying 141 - 160 of 59293

Sort: Relevancy | Date

News Conference News THT 2026

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

Todd Neale

March 03, 2026

Presentation THT 2026

Serum and Urine Concentrations of Sodium (Na+) and Potassium (K+) after a Single Subcutaneous (SC) Injection of a Novel Formulation of Furosemide (FUR)

Presenter: John F. Mohr

March 03, 2026

Presentation THT 2026

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Presenter: Jozef Bartunek

March 03, 2026

Presentation THT 2026

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Presenter: Andrea Russo

March 03, 2026

Presentation THT 2026

Debate: A Patient With MR Not Improving With GDMT: Go to VAD

Presenter: Jaya Batra

March 03, 2026

Presentation THT 2026

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Presenter: Barry Borlaug

March 03, 2026

Presentation THT 2026

Debate: A Patient With MR Not Improving With GDMT: Try mTEER

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

Presenter: Robert Anthony Adamian

March 03, 2026

Presentation THT 2026

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Presenter: Dmitry Yaranov

March 03, 2026

Presentation THT 2026

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Presenter: Nicolas M. Van Mieghem

March 03, 2026

Presentation THT 2026

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

Exercise-Induced MR: Implications for Diagnosis and Treatment

Presenter: Nikhil Narang

March 03, 2026

News Daily News

AHA Forecast: CV Risk Factors in Women, Girls Headed in Wrong Direction

L.A. McKeown

March 03, 2026

Presentation THT 2026

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Presenter: Brad Williams

March 03, 2026

Presentation THT 2026

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Presenter: Alex Rothman

March 03, 2026

Presentation THT 2026

Medical Therapy for TR

Presenter: Sean P. Pinney

March 03, 2026

Presentation THT 2026

Anatomic Considerations for T-TEER and TTVR

Presenter: Jörg Hausleiter

March 03, 2026

Advertisement

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

Serum and Urine Concentrations of Sodium (Na+) and Potassium (K+) after a Single Subcutaneous (SC) Injection of a Novel Formulation of Furosemide (FUR)

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes after Interatrial Shunting in Heart Failure

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Debate: A Patient With MR Not Improving With GDMT: Go to VAD

Percutaneous Pericardiotomy as a Treatment for HFpEF (Heart Failure Solutions)

Debate: A Patient With MR Not Improving With GDMT: Try mTEER

Psoas Muscle Recovery After LVAD Implantation is Associated with Decreased Risk of Heart Failure Readmission in Cardiogenic Shock Patients

LVEF and Functional Improvement Observed in a Post-Market Registry of Barostim Baroreflex Activation Therapy

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Levosimendan: Mechanisms and Clinical Effects as a Treatment for PH-HFpEF

Real-World Outcomes of Barostim Baroreflex Activation Therapy in Heart Failure: Analysis of a Large Multi-Institutional Database.

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Exercise-Induced MR: Implications for Diagnosis and Treatment

AHA Forecast: CV Risk Factors in Women, Girls Headed in Wrong Direction

Impact of Pharmacist Virtual Consultation on GDMT Optimization in Hospitalized Patients

Cardiogenic Shock with Cardiac Arrest: Does It Always Represent SCAI Stage E?

Ultrasound Pulmonary Artery Denervation as a Treatment for Heart Failure (Gradient Medical)

Medical Therapy for TR

Anatomic Considerations for T-TEER and TTVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content